- Home
- VSTM vs GAIN Comparison
VSTM vs GAIN Comparison
Compare VSTM & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- GAIN
- Stock Information
- Founded
- VSTM 2010
- GAIN 2005
- Country
- VSTM United States
- GAIN United States
- Employees
- VSTM N/A
- GAIN N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- GAIN Finance: Consumer Services
- Sector
- VSTM Health Care
- GAIN Finance
- Exchange
- VSTM Nasdaq
- GAIN Nasdaq
- Market Cap
- VSTM 493.6M
- GAIN 522.8M
- IPO Year
- VSTM 2012
- GAIN 2005
- Fundamental
- Price
- VSTM $8.85
- GAIN $14.11
- Analyst Decision
- VSTM Strong Buy
- GAIN Buy
- Analyst Count
- VSTM 9
- GAIN 2
- Target Price
- VSTM $13.38
- GAIN $14.00
- AVG Volume (30 Days)
- VSTM 2.2M
- GAIN 153.6K
- Earning Date
- VSTM 11-04-2025
- GAIN 11-04-2025
- Dividend Yield
- VSTM N/A
- GAIN 15.60%
- EPS Growth
- VSTM N/A
- GAIN 8.96
- EPS
- VSTM N/A
- GAIN 2.16
- Revenue
- VSTM $2,137,000.00
- GAIN $95,028,000.00
- Revenue This Year
- VSTM $79.32
- GAIN $6.54
- Revenue Next Year
- VSTM $413.52
- GAIN $4.49
- P/E Ratio
- VSTM N/A
- GAIN $6.52
- Revenue Growth
- VSTM N/A
- GAIN 6.55
- 52 Week Low
- VSTM $3.19
- GAIN $11.42
- 52 Week High
- VSTM $11.25
- GAIN $15.34
- Technical
- Relative Strength Index (RSI)
- VSTM 51.64
- GAIN 54.94
- Support Level
- VSTM $7.60
- GAIN $13.72
- Resistance Level
- VSTM $9.16
- GAIN $14.15
- Average True Range (ATR)
- VSTM 0.66
- GAIN 0.25
- MACD
- VSTM -0.02
- GAIN 0.04
- Stochastic Oscillator
- VSTM 61.99
- GAIN 90.89
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About GAIN Gladstone Investment Corporation Business Development Company
Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.